BlackRock, Inc. - Mar 31, 2025 SCHEDULE 13G/A Report for Allogene Therapeutics, Inc Common Stock (ALLO)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Allogene Therapeutics, Inc Common Stock
Symbol: ALLO
Shares outstanding: 216M shares
Disclosed Ownership: 11.5M shares
Ownership: 5.3%
Form type: SCHEDULE 13G/A
Date filed: 4/17/2025, 09:35 AM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.3%	11.5M	11.3M	0	Spencer Fleming	Managing Director